B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.
about
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodiesEffects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host SurvivalControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentTherapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentMonitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesImmunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanomaB cells and the humoral response in melanoma: The overlooked players of the tumor microenvironmentB cells inhibit the antitumor immunity against an established murine fibrosarcomaThe roles of regulatory B cells in cancerProlonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancerAcute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in miceCuring mice with large tumors by locally delivering combinations of immunomodulatory antibodies.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regressionRegulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growthTargeting CD20 in melanoma patients at high risk of disease recurrence.Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma.Chronic alcohol consumption impairs distribution and compromises circulation of B cells in B16BL6 melanoma-bearing mice.Immune microenvironment in tumor progression: characteristics and challenges for therapyInhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanismsCD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote CancerTargeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.Autologous immune enhancement therapy: A case report of a stage IV colonic cancer.Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammationCross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma.B lymphocytes differentially influence acute and chronic allograft rejection in miceType III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma.Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.B-lymphocyte effector functions in health and disease.B lymphocytes as effector cells in the immunotherapy of cancer.
P2860
Q24598772-447F72BE-D82A-4B65-9A40-0964E700FB9CQ26773212-D16B9F67-D1B0-4C0B-B9B9-D23006E47062Q26799117-2B3B00D2-60BA-4D83-8A9D-88D108BC3B64Q26799123-C12F1C51-397D-49FD-9EB5-C20DBA3D75C4Q27345217-5CB40F3F-74C5-43A0-8C51-740DA49A700DQ30422102-FAF0EBDA-0A38-4979-858C-E1F6AC3CDFDEQ33632113-E37789C8-02DF-46BA-AF78-2A7F6E326D64Q33684762-70F9D6FF-3642-4DDB-A326-6A92A6B3782BQ33765986-95D700DA-F43D-45D1-9071-C03E6098A3E1Q33964275-82A156C9-F8FC-44C8-A8AF-7A5F46070847Q34002125-A80CF089-ADDA-40F3-A063-4F2D3EAB5BCEQ34103969-DBF11A90-D4FD-48A9-AC07-4082755C103FQ34341357-58D6459E-8598-4C54-B7AF-A97584270432Q34364876-E51E02D3-48C1-4074-89A9-F1ACEF70FDB7Q34541239-B6CF97E9-D5CC-460C-AD68-468FD99D8582Q34909225-AFF83633-B353-4B9D-9870-167A6CB98C79Q35107009-E042421F-7F59-4649-8D0C-134C83D75FA9Q35110486-42CCB36B-5600-44E4-AFAF-83C5DE42F893Q35146131-B372F8C2-8DA8-4016-9E12-FE32D75156D9Q35866355-4A891B80-5E8C-401F-8B30-21FDBE1D7783Q35939451-33D904FD-D282-4231-BB78-16ED24C59902Q36022359-34A7100B-027A-4177-8C01-29BC9FB18F16Q36132281-4A02C5EA-6DD7-4E2C-8F12-6CFBDAB52BD8Q36178400-41274FBA-593E-4343-8F01-D9131040EF07Q36233927-73789758-8EB0-4AFF-8E89-8E44BB91C485Q36800456-8BD273A7-983A-44E6-9745-147649F836B7Q36832883-1329B40F-2A3B-47A1-BE60-C46674D29BEEQ36864003-52B00722-ABD0-42A8-ABC3-C6A00B950EC4Q36919283-926FEB1F-398D-41A5-B1F3-AA99260D6E95Q36927352-CD0ECA1A-A2A7-44B4-993E-E36B13C3333DQ36936462-898A4A25-5943-4D43-8E43-04580642771BQ37046631-836EBC10-441B-4E6E-B5F5-11AE8E866815Q37072826-4D519990-AF5A-4FE7-ACA2-72DA0ECDD872Q37123849-DC5D7571-9BC7-48CE-A755-B5C11930E081Q37175625-5CA62F0E-4300-40A8-B836-EBE3CFF6E31DQ37469720-CFFA4E7A-DB46-47BF-BCB1-F359D2E4B784Q37525296-C6F0DE94-3838-4917-8AAF-DC220D560C0DQ37548776-09244161-5069-4D2C-93E7-CE583A25CE2FQ37815038-56B74749-16CD-436B-9C41-1FB73698F77BQ37928542-FAC01354-D9E9-467F-B4AA-52A81D39E394
P2860
B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
B cells are required for optim ...... s B16 melanoma growth in mice.
@en
B cells are required for optim ...... s B16 melanoma growth in mice.
@nl
type
label
B cells are required for optim ...... s B16 melanoma growth in mice.
@en
B cells are required for optim ...... s B16 melanoma growth in mice.
@nl
prefLabel
B cells are required for optim ...... s B16 melanoma growth in mice.
@en
B cells are required for optim ...... s B16 melanoma growth in mice.
@nl
P2093
P2860
P356
P1476
B cells are required for optim ...... s B16 melanoma growth in mice.
@en
P2093
David J DiLillo
Koichi Yanaba
Thomas F Tedder
P2860
P304
P356
10.4049/JIMMUNOL.0903009
P407
P577
2010-03-01T00:00:00Z